The findings, published in the RANZCO Journal of Clinical and Experimental Ophthalmology, suggest obstructive sleep apnoea (OSA) could be a modifiable ...
Founded by a team of leading sleep health physicians and dentists, we're revolutionizing the way sleep apnea is diagnosed and treated. Our mission is to reshape the health trajectories of millions ...
Incannex's novel drug to treat Obstructive Sleep Apnea has completed dosing for the Phase 2/3 FDA trial. IXHL has received IND clearance from the FDA for its PSX-001 drug, designed to treat ...
People with high blood pressure who also lack sleep may be at increased risk of reduced cognitive performance and greater brain injury, Monash University research has found.